ACNE MEDICINE REVIEW:

Beauty Mavens Given a Taste of Revolutionary New Acne Product: Frutels Gummy Vitamins for Acne Now Sold in All Ricky's PR Newswire via Yahoo! Finance
Teens and other acne sufferers, tired of topical creams and cleansers promising that ever-elusive Hollywood skin, can now purchase a radically different skincare product to fight their acne.
Fostering A New Medical Life For A Forgotten Antibiotic Science Daily
The increasing need for new antibiotics to combat multidrug-resistant bacteria has led chemists to develop the first method for synthesizing a potentially valuable antibiotic that has been sidelined from clinical use for 40 years.
Shire Bioequivalence Study Results Of SPD465, Investigational Drug For Adults With ADHD Medical News Today
Shire plc (LSE: SHP, NASDAQ: SHPGY, TSX: SHQ) announced that a single once-daily morning dose of the investigational amphetamine compound SPD465, extended release triple-bead mixed amphetamine salts, designed to reduce symptoms of Attention-Deficit/Hyperactivity Disorder (ADHD) in adults for up to 16 [click link for full article]
Diagnosis and Management of Granuloma Annulare American Family Physician
PEGGY R. CYR, M.D., Maine Medical Center, Portland, Maine Granuloma annulare is a benign, asymptomatic, self-limited papular eruption found in patients of all ages.
Shire Announces Results Of Its Bioequivalence Study Of SPD465, An Investigational Drug For Adults With ADHD Medical News Today
Shire plc (LSE: SHP, Nasdaq: SHPGY, TSX: SHQ) announced today that a single once-daily morning dose of the investigational amphetamine compound SPD465, extended release triple-bead mixed amphetamine salts, designed to reduce symptoms of Attention-Deficit/Hyperactivity Disorder (ADHD) in adul [click link for full article]
Shire bioequivalence study results of SPD465, investigational drug for adults with ADHD EurekAlert!
New Orleans – November 16, 2006 -- Shire plc (LSE: SHP, NASDAQ: SHPGY, TSX: SHQ) announced today that a single once-daily morning dose of the investigational amphetamine compound SPD465, extended release triple-bead mixed amphetamine salts, designed to reduce symptoms of Attention-Deficit/Hyperactivity Disorder (ADHD) in adults for up to 16 hours, was bioequivalent to a dose of ADDERALL XR (mixed
Shire Announces Results of its Bioequivalence Study of SPD465, an Investigational Drug for Adults with ADHD PR Newswire via Yahoo! Finance
Shire plc announced today that a single once-daily morning dose of the investigational amphetamine compound SPD465, extended release triple-bead mixed amphetamine salts, designed to reduce symptoms of Attention-Deficit/Hyperactivity Disorder in adults for up to 16 hours, was bioequivalent to a dose of ADDERALL XR followed by a dose of mixed amphetamine salts immediate release eight hours later.
acne+medicine+review: acne+medicine+review